Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,787 results for ""Tazobactam""

Your Filters

Subject : meropenem
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage.

  • Authors : Fouad A; Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT, USA.; Nicolau SE

Subjects: Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects ; Cephalosporins*/Cephalosporins*/Cephalosporins*/pharmacology ; Meropenem*/Meropenem*/Meropenem*/pharmacology

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 May 02; Vol. 79 (5), pp. 1176-1181.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents.

Subjects: Microbial Sensitivity Tests* ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 May 02; Vol. 68 (5), pp. e0136323. Date of Electronic Publication: 2024 Mar 25.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.

  • Authors : Timsit JF; Intensive Care Medicine Department, Université Paris Diderot, Paris, France.; Huntington JA

Subjects: Cephalosporins/Cephalosporins/Cephalosporins/*standards ; Healthcare-Associated Pneumonia/Healthcare-Associated Pneumonia/Healthcare-Associated Pneumonia/*drug therapy ; Meropenem/Meropenem/Meropenem/*standards

  • Source: Critical care (London, England) [Crit Care] 2021 Aug 11; Vol. 25 (1), pp. 290. Date of Electronic Publication: 2021 Aug 11.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Outcomes in Participants with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane/Tazobactam Treatment of Nosocomial Pneumonia (ASPECT-NP).

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use ; Cephalosporins*/Cephalosporins*/Cephalosporins*/therapeutic use ; Cross Infection*/Cross Infection*/Cross Infection*/drug therapy

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2020 Nov 17; Vol. 64 (12). Date of Electronic Publication: 2020 Nov 17 (Print Publication: 2020).Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).

Subjects: Cost-Benefit Analysis*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Azabicyclo Compounds/Azabicyclo Compounds/Azabicyclo Compounds/*therapeutic use

  • Source: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2019 Dec 21; Vol. 8, pp. 204. Date of Electronic Publication: 2019 Dec 21 (Print Publication: Publisher: BioMed Central Country of Publication: England NLM ID: 101585411 Publication Model: eCollection Cited Medium: Internet ISSN: 2047-2994

Record details

Read More Add to Saved list
×
Academic Journal

Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Cephalosporins/Cephalosporins/Cephalosporins/*therapeutic use ; Cross Infection/Cross Infection/Cross Infection/*drug therapy

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2019 Dec; Vol. 19 (12), pp. 1299-1311. Date of Electronic Publication: 2019 Sep 25.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.

  • Authors : Robertson AD; Department of Pharmacy Practice, University of Arkansas for Medical Sciences Northwest Regional Campus, Fayetteville, Arkansas.; Mercy Hospital Northwest Arkansas, Rogers, Arkansas.

Subjects: Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*chemically induced ; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*adverse effects ; Meropenem/Meropenem/Meropenem/*adverse effects

  • Source: Pharmacotherapy [Pharmacotherapy] 2018 Dec; Vol. 38 (12), pp. 1184-1193. Date of Electronic Publication: 2018 Oct 03.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem.

  • Authors : Blevins AM; Department of Pharmacy, The University of Kansas Health System, Kansas City, Kansas, USA.; Lashinsky JN

Subjects: Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*epidemiology ; Cefepime/Cefepime/Cefepime/*therapeutic use ; Meropenem/Meropenem/Meropenem/*therapeutic use

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2019 Apr 25; Vol. 63 (5). Date of Electronic Publication: 2019 Apr 25 (Print Publication: 2019).Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Preanalytical Stability of Piperacillin, Tazobactam, Meropenem, and Ceftazidime in Plasma and Whole Blood Using Liquid Chromatography-Tandem Mass Spectrometry.

  • Authors : Mortensen JS; Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.; Jensen BP

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*blood ; Ceftazidime/Ceftazidime/Ceftazidime/*blood ; Meropenem/Meropenem/Meropenem/*blood

  • Source: Therapeutic drug monitoring [Ther Drug Monit] 2019 Aug; Vol. 41 (4), pp. 538-543.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients.

  • Authors : Heil EL; University of Maryland School of Pharmacy, Baltimore, Maryland, USA .; Nicolau DP

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacology ; Cefepime/Cefepime/Cefepime/*pharmacology ; Meropenem/Meropenem/Meropenem/*pharmacology

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2018 Aug 27; Vol. 62 (9). Date of Electronic Publication: 2018 Aug 27 (Print Publication: 2018).Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  1,787 results for ""Tazobactam""